文献

J-GLOBAL ID：201902202042339190   整理番号：19S1330177

Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): An open-label, non-inferiority, randomised phase 3 trial

著者 (16件)： Takashima, Tsutomu (Osaka City University Graduate School of Medicine) ,  Mukai, Hirofumi (National Cancer Center Hospital East) ,  Matsubara, Nobuaki (National Cancer Center Hospital East) ,  Hara, Fumikata (National Hospital Organization Shikoku Cancer Center) ,  Saito, Tsuyoshi (Saitama Red Cross Hospital) ,  Takano, Toshimi (Toranomon Hospital) ,  Park, Youngjin (Tohoku Pharmaceutical University Hospital) ,  Toyama, Tatsuya (Nagoya City University Graduate School of Medical Sciences) ,  Hozumi, Yasuo (Jichi Medical University) ,  Tsurutani, Junji (Kinki University Faculty of Medicine) ,  Imoto, Shigeru (School of Medicine Kyorin University) ,  Watanabe, Takanori (National Hospital Organization Sendai Medical Center) ,  Sagara, Yoshiaki (Hakuaikai Medical Corp Sagara Hospital) ,  Nishimura, Reiki (Kumamoto Shinto General Hospital) ,  Shimozuma, Kojiro (Ritsumeikan University) ,  Ohashi, Yasuo (Chuo University)
資料名： The Lancet Oncology
巻： 17  号： 1  ページ： 90-98  発行年： 2016年 
JST資料番号： SCOPUS  ISSN： 1470-2045  CODEN： LOANB 
発行国： イギリス (GBR)  言語： 英語 (EN)

タイトルに関連する用語 (1件)： Cancer